GLP-1 R is a triple-agonist peptide designed to activate the GLP-1, GIP, and glucagon receptors, offering an innovative approach to metabolic optimization, weight management, and overall metabolic health. This cutting-edge product represents a new frontier in peptide-based therapies for obesity, insulin resistance, and cardiometabolic health.
Key Benefits for Your Patients:
- Comprehensive Weight Management: Promotes significant reductions in body fat through enhanced metabolic signaling.
- Improved Glycemic Control: Supports insulin sensitivity and glucose regulation for patients with metabolic syndrome or type 2 diabetes.
- Cardiometabolic Support: May reduce key risk markers associated with cardiovascular disease and inflammation.
- Enhanced Energy Utilization: Improves mitochondrial efficiency, supporting sustained energy and fat oxidation.
- Synergistic Peptide Innovation: Combines GLP-1, GIP, and glucagon receptor activation for superior metabolic modulation.
Our lyophilized GLP-1 R delivers 99%+ purity and is manufactured in the USA. We partner exclusively with FDA-registered and inspected facilities to ensure that every ingredient meets stringent purity and efficacy benchmarks, guaranteeing consistency and efficacy across all production runs. Certificate of Analysis available upon request.
Each vial is provided in lyophilized powder form and must be reconstituted with bacteriostatic water prior to use.
This product is intended for use under the guidance of qualified medical professionals who prioritize precision, quality, and evidence-based peptide therapies in patient care.
